Muhammad Anwar
Anesthesiology · Durham, NCNPI 1144682386
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 27.4% of the total. Reporting peaked in 2022 at $3,897 and has fallen 95.6% since, to $171 in 2025. Among anesthesiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $120.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Abbott$2K
- Nevro Corp.$658
- MML US, Inc.$422
- Saluda Medical Americas, Inc.$413
- plus $567 from 3 others
What the payments were for
- Travel & lodging$3,36247%
- Food & beverage$3,85553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $1,979 |
| Boston Scientific | 7 | $1,669 |
| Abbott | 12 | $1,509 |
| Nevro Corp. | 6 | $658 |
| MML US, Inc. | 2 | $422 |
| Saluda Medical Americas, Inc. | 4 | $413 |
| SPR Therapeutics, Inc | 4 | $352 |
| Johnson & Johnson | 2 | $124 |
| GRT US Holding, Inc. | 1 | $91 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,295
- PROCLAIM$1,224
- KYPHON EXPRESS II KYPHOPAK TRAY$797
- ReActiv8$422
- Omnia$350
- INTELLIS ADAPTIVESTIM$273
- SPRINT PNS System$260
- Senza$241
- VECTRIS SURESCAN$235
- Evoke$227
- Proclaim IPG$153
- OSTEOCOOL RF ABLATION SYSTEM$132
- Evoke SCS$101
How this compares
$7,217 in reported general payments places this provider in the 95th percentile of 1,149 anesthesiology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 14 | $7,811 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $5,719 |
| Buprenorphine | 18 | $5,458 |
| Pregabalin | 115 | $1,966 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $1,956 |
| Naloxone Hcl | 24 | $1,357 |
| Gabapentin | 123 | $1,334 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $1,162 |
| Tizanidine Hcl | 63 | $1,130 |
| Oxycodone Hcl | 46 | $1,088 |
| Baclofen | 47 | $677 |
| Duloxetine Hcl | 65 | $659 |
| Nortriptyline Hcl | 50 | $625 |
| Diclofenac Sodium | 21 | $568 |
| Buprenorphine Hcl | 12 | $552 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Durham
- Jeffrey GadsdenDurham$821K
- Jerrold LevyDurham$305K
- Alicia WarlickDurham$127K
- William BullockDurham$126K
- Karthik RaghunathanDurham$123K
- Scott RunyonDurham$123K
- Neel ThomasDurham$83K
- Timothy MillerDurham$77K
- Lance RoyDurham$60K
- Christopher YoungDurham$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.